Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Selva-O'Callaghan, A.
Right arrow Articles by Vilardell-Tarrés, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Selva-O'Callaghan, A.
Right arrow Articles by Vilardell-Tarrés, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2000; 39: 914-916
© 2000 British Society for Rheumatology

Respiratory failure due to muscle weakness in inflammatory myopathies: maintenance therapy with home mechanical ventilation

A. Selva-O'Callaghan, L. Sanchez-Sitjes, X. Muñoz-Gall1, T. Mijares-Boeckh-Behrens, R. Solans-Laque, J. Angel Bosch-Gil, F. Morell-Brotad1 and Miguel Vilardell-Tarrés

Department of Internal Medicine and
1 Pneumology Service, Vall D'Hebron General Hospital, Barcelona, Spain

Polymyositis and dermatomyositis are idiopathic inflammatory myopathies. Respiratory complications are a common feature, but ventilatory insufficiency is rare in these patients. We describe here three patients diagnosed with inflammatory myopathy (polymyositis) with respiratory failure due to muscle weakness who did not respond to immunosuppressive therapy. Mechanical ventilation at home with nasal or tracheal intermittent positive pressure resulted in improved chronic hypoventilation. This treatment improves the quality of life of patients with inflammatory myopathies and can be lifesaving in some cases.

KEY WORDS: Pulmonary, Polymyositis/dermatomyositis, Evaluation of new systems of care.

Correspondence to: A. Selva-O'Callaghan, C/ Siracusa No. 12 bis A, Barcelona 08012, Spain.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 LupusHome page
A Selva-O'Callaghan, M Labrador-Horrillo, X Munoz-Gall, X Martinez-Gomez, J Majo-Masferrer, R Solans-Laque, C P Simeon-Aznar, F Morell-Brotard, and M Vilardell-Tarres
Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients
Lupus, July 1, 2005; 14(7): 534 - 542.
[Abstract] [PDF]

Home page
 Rheumatology (Oxford)Home page
C. Korkmaz, G. Temiz, F. Cetinbas, and B. Buyukkidan
Successful treatment of alveolar hypoventilation due to dermatomyositis with anti-tumour necrosis factor-alpha
Rheumatology, July 1, 2004; 43(7): 937 - 938.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.